EU treatment milestone as dostarlimab approved for eligible patients with endometrial cancer
Hospital Pharmacy Europe
DECEMBER 14, 2023
Dostarlimab (brand name Jemperli) has been granted marketing authorisation by the European Commission (EC) in combination with carboplatin-paclitaxel (chemotherapy) for certain types of endometrial cancer, its manufacturer GSK has announced.
Let's personalize your content